Trial intelligence / Profile preview

Phase 3 cetirizine dry syrup in children with atopic dermatitis

jRCT2080220120Phase 3

Sponsor
GSK
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of cetirizine in atopic dermatitis (AD), sponsored by GSK.

02

Drugs

cetirizine
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on jRCT2080220120.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080220120.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call